CSL

CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.

Areas of Expertise

We focus and demonstrate global leadership in three distinct areas—rare and serious diseases; influenza vaccines; and iron deficiency and nephrology.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.

As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries.

With our iron deficiency and iron deficiency anemia expertise in heart failure, kidney disease, gastroenterology or inflammatory bowel disease, patient blood management and women’s health, we help patients affected by these conditions to live better, healthier lives.

  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
1020 First Avenue
King of Prussia, PA 19406
  • Featured Employer
Join us in our relentless pursuit
of innovation! From lifesaving
treatments to groundbreaking
vaccines, we’re rewriting the future.

CSL Behring

A global leader in biotherapies for rare and serious conditions like bleeding disorders and immunodeficiencies.

CSL Seqirus

Focused on developing essential vaccines to protect people of all ages from infectious diseases.

CSL Vifor

Providing innovative treatments for patients with chronic kidney disease and iron deficiency.

CSL Plasma

One of the world’s largest plasma collection networks, ensuring a critical source of lifesaving therapies.

CSL Supports Your Well-Being

We recognize your job is only a part of who you are. CSL supports the whole employee, which is why employee benefits and perks are a part of what makes a Promising Future at CSL so special. Here’s what sets your journey apart:

Continuously develop your skills through training programs, tuition reimbursement and opportunities to take on new challenges.

Enjoy a competitive benefits package that includes financial planning resources, paid time off and more local benefits, depending on location.

We prioritize your well-being with on-site wellness programs, mental health resources and flexible work arrangements to help you thrive.

NEWS
It was a fairly busy week with clinical trial updates and announcements. Here’s a look.
CSL Behring, based in King of Prussia, Pennsylvania, is acquiring Vancouver, British Columbia-based Vitaeris. The two companies inked a strategic partnership in 2017 to accelerate the development of Vitaeris’s clazakizumab. At that time, CLS Behring also had an option to acquire Vitaeris, the therapeutic, and the rest of Vitaeris’s assets.
CSL Behring has developed a number of strategies to address COVID-19, the disease caused by the novel coronavirus that originated in China and spread across the globe in a matter of months.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
Here are five high-quality examples of major bio organizations’ efforts to showcase their commitment to providing a positive D&I work environment.
Netherlands-based Pharming Group NV has denied any involvement in a potential theft of intellectual property belonging to CSL Behring from Joseph Chiao, who recently joined Pharming as medical director.
Pharming categorically denies having had any involvement in the alleged abstraction of proprietary information by Dr Joseph Chiao from his former employer CSL
JOBS
IN THE PRESS